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Background
Recent successes with experimental PD-L1 and PD-1
drugs and with adoptive immunotherapy point to the tre-
mendous potential clinical value of harnessing our
immune systems to fight cancer. Assessing host interac-
tion with malignant cells is most effectively achieved by
phenotyping cell types in-situ in intact tissue sections. Spa-
tial relationships and phenotype patterns can potentially
predict response to immunotherapies and monitor effi-
cacy. However, methods to perform such analyses have
proven elusive due to challenges of multicolor labeling
and image analysis. We report progress toward an inte-
grated approach, combining new multiplexed labeling and
imaging-based analysis, to capture expression and contex-
tual information and reduce data to actionable metrics. In
this study, we demonstrate the capability on control sam-
ples (tonsil) and a cohort of clinical breast cancer samples,
by comparing automated and visual assessments.
Methods
De-identified, excess clinical samples, tonsil and four
breast cancer biopsies, were labeled for CD4, CD8, CD20,
cytokeratin, and DAPI with a new serial same-species
fluorescence labeling approach utilizing tyramide signal
amplification (TSA), and microwave-based antigen retrie-
val and antibody stripping. Labels are added sequentially,
each amplified independently, to achieve specific, robust,
balanced labeling. Samples were imaged on the Vectra
multispectral system, and analyzed with inForm pattern
recognition software, which segments tissue into tumor
and stroma and phenotypes cells as epithelial, killer
T-cells, helper T-cells, and B-cells, or other, producing
cell phenotype maps retaining spatial arrangements.
Imagery was then carefully assessed by a pathologist for
segmentation and cell phenotyping accuracy, and for dis-
tinguishing inter- versus intra-epithelial cells.
Results
Labeling of tonsil samples demonstrate specificity and
sensitivity estimated by a pathologist to be greater than
95%. On breast cancer samples, comparable accuracy
was achieved except for areas of necrosis where it was
somewhat less. More importantly, in breast cancer sam-
ples, distinguishing inter- and intra-epithelial immune
cells was estimated to be nearly perfect, despite signifi-
cant inflammation in non-epithelial areas immediately
adjacent to tumor, in some samples.
Conclusions
The approach shows reliable detection of phenotypes
and accurate segmentation of tumor and stroma regions,
to accurately assess interaction between immune cells
and tumor mass, such as infiltration. We believe results
support the feasibility of a practical and viable clinical
workflow, in which immune response assessment is
automated by computer and results are reviewed by
pathologists to assure data quality.
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